Search Result "relapsed Hodgkin Lymphoma"


mTOR as a Target of Everolimus in Refractory/Relapsed Hodgkin Lymphoma

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 7 Year: 2012 Page: 945-954
Author(s): A. Guarini, C. Minoia, M. Giannoccaro, A. Rana, A. Iacobazzi, A. Lapietra, A. Raimondi, N. Silvestris, C. D. Gadaleta, G. Ranieri

Impact of PET on the Radiation Treatment of Hodgkins Lymphoma

Journal: Current Radiopharmaceuticals
Volume: 2 Issue: 3 Year: 2009 Page: 169-174
Author(s): Annibale Versari, Cinzia Iotti, Francesco Merli

Hodgkin Lymphoma in HIV Positive Patients

Journal: Current HIV Research
Volume: 8 Issue: 2 Year: 2010 Page: 141-146
Author(s): Nicolas Mounier, Michele Spina, Jean P. Spano

Antibody-Targeted Immunotherapy for Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 1 Issue: 4 Year: 2000 Page: 303-312
Author(s): Christine A. White, Judy R. Berlfein, Antonio J. Grillo-Lopez

Physiopathogenesis of Lymphoma

Ebook: Physiopathogenesis of Hematological Cancer
Volume: 1 Year: 2012
Author(s): Edgar Gil Rizzatti
Doi: 10.2174/978160805259211201010151

Non-Hodgkins Lymphoma: Review of Conventional Treatments

Journal: Current Pharmaceutical Biotechnology
Volume: 2 Issue: 4 Year: 2001 Page: 279-291
Author(s): P. Multani, C.A. White, A. Grillo-Lopez

Radioimmunotherapy of Non-Hodgkins Lymphomas

Journal: Current Drug Targets
Volume: 7 Issue: 1 Year: 2006 Page: 1293-1300
Author(s): Bruce D. Cheson

Perspective

Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor forTreating Relapsed or Refractory Mantle Cell Lymphoma in Adults

Journal: Current Medicinal Chemistry
Volume: 31 Issue: 30 Year: 2024 Page: 4757-4762
Author(s): Surya K. De

Research Article open access plus

Pharmacokinetic and Pharmacodynamic Relationship of Blinatumomab in Patients with Non-Hodgkin Lymphoma

Journal: Current Clinical Pharmacology
Volume: 13 Issue: 1 Year: 2018 Page: 55-64
Author(s): Youssef Hijazi,Matthias Klinger,Andrea Kratzer,Benjamin Wu,Patrick A. Baeuerle,Peter Kufer,Andreas Wolf,Dirk Nagorsen,Min Zhu

Rituxan® Immunotherapy and Zevalin® Radioimmunotherapy in the Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 4 Issue: 4 Year: 2003 Page: 221-238
Author(s): Christine A. White

Previous   Next

Go To   Results 1 - 1 of 791

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy